Hematoloxía e Hemoterapia
![Foto de Hematoloxía e Hemoterapia](/img/grupo.png)
![Foto de Complejo Asistencial Universitario de Burgos](/img/noimage_org.png)
Complejo Asistencial Universitario de Burgos
Burgos, EspañaPublicacións en colaboración con investigadores/as de Complejo Asistencial Universitario de Burgos (8)
2024
-
Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice
Blood, Vol. 144, Núm. 6, pp. 646-656
2023
-
Recommendations for the Clinical Approach to Immune Thrombocytopenia: Spanish ITP Working Group (GEPTI)
Journal of Clinical Medicine, Vol. 12, Núm. 20
2021
-
A decade of changes in management of immune thrombocytopenia, with special focus on elderly patients
Blood Cells, Molecules, and Diseases, Vol. 86
-
Author Correction: Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia (Scientific Reports, (2019), 9, 1, (16680), 10.1038/s41598-019-53209-y)
Scientific Reports
-
Long-Term Outcomes After Autologous Versus Allogeneic Stem Cell Transplantation in Molecularly-Stratified Patients With Intermediate Cytogenetic Risk Acute Myeloid Leukemia: A PETHEMA Study
Transplantation and Cellular Therapy, Vol. 27, Núm. 4, pp. 311.e1-311.e10
2020
-
Use of eltrombopag for patients 65 years old or older with immune thrombocytopenia
European Journal of Haematology, Vol. 104, Núm. 3, pp. 259-270
2019
2017
-
Use of eltrombopag for secondary immune thrombocytopenia in clinical practice
British Journal of Haematology, Vol. 178, Núm. 6, pp. 959-970